AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30969147 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPS-Plus and TIPS-Basic
Number of subjects: 240
Study 28375035 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (5-10 µg/kg/min) in combination with propofol and remifentanil
Number of subjects: 56
Study 28375035 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (same volume as esmolol) in addition to propofol and remifentanil
Number of subjects: 56
Study 26375604 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule formulations with hydroxypropyl methylcellulose (HPMC)
Number of subjects: 72
Study 26375604 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule formulations with magnesium stearate
Number of subjects: 72
Study 26375604 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine commercial solution containing sorbitol
Number of subjects: 72
Study 26375604 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule formulations with lower amounts of HPMC and magnesium stearate
Number of subjects: 72
Study 26375604 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbitol-containing commercial solution
Number of subjects: 72
Study 26375604 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbitol-free solution
Number of subjects: 72
Study 26375604 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 common excipients in large amounts
Number of subjects: 72
Study 26375604 — intervention group
Group type: EXPERIMENTAL
Intervention: HPMC and microcrystalline cellulose
Number of subjects: 72
Study 24879885 — intervention group
Group type: EXPERIMENTAL
Intervention: Green low-fat label
Number of subjects: 287
Study 24879885 — intervention group
Group type: EXPERIMENTAL
Intervention: Red high-fat label
Number of subjects: 287
Study 24879885 — intervention group
Group type: COMPARATOR
Intervention: No label
Number of subjects: 287
Study 22084448 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS® methylphenidate (Concerta®)
Number of subjects: 139
Study 22084448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study 19717185 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin (0.75 mg/kg intravenous bolus followed by 1.75 mg/kg per h infusion)
Number of subjects: 3602
Study 19717185 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 3602
Study 19717185 — intervention group
Group type: COMPARATOR
Intervention: Heparin plus GPI (control)
Number of subjects: 3602
Study 18003960 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab (400 mg/m² initial dose followed by 250 mg/m² weekly) plus best supportive care
Number of subjects: 572
Study 18003960 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care alone
Number of subjects: 572
Study 14974945 — intervention group
Group type: EXPERIMENTAL
Intervention: EC‐MPS (720 mg b.i.d.)
Number of subjects: 322
Study 14974945 — intervention group
Group type: COMPARATOR
Intervention: MMF (1000 mg b.i.d.)
Number of subjects: 322
Study 11261909 — intervention group
Group type: EXPERIMENTAL
Intervention: Admixture of thiopentone and propofol (1.25% and 0.5% respectively)
Number of subjects: 81
Study 11261909 — intervention group
Group type: COMPARATOR
Intervention: Propofol 1%
Number of subjects: 81
Study 9557929 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills (ethinyl-oestradiol plus levonorgestrel)
Number of subjects: 32
Study 9557929 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 32
Study 9557929 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills
Number of subjects: 32
Study 8300688 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified over-the-top (OTT) procedure
Number of subjects: 54
Study 8300688 — intervention group
Group type: COMPARATOR
Intervention: Tunnel position obtained by an isometric drill guide (ISO)
Number of subjects: 54
Study 2656775 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg twice daily)
Number of subjects: 23
Study 2656775 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg twice daily)
Number of subjects: 23
Study 31552577 — intervention group
Group type: COMPARATOR
Intervention: Carfilzomib-based therapy
Number of subjects: 0
Study 31552577 — intervention group
Group type: COMPARATOR
Intervention: Daratumumab-based therapy
Number of subjects: 0
Study 31453723 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (MOD; 55% peak oxygen uptake)
Number of subjects: 10
Study 31453723 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (HIGH; 75% peak oxygen uptake)
Number of subjects: 10
Study 31453723 — intervention group
Group type: COMPARATOR
Intervention: Control (CON; rest)
Number of subjects: 10
Study 28688245 — intervention group
Group type: EXPERIMENTAL
Intervention: 5mg prednisolone in the evening
Number of subjects: 8
Study 28688245 — intervention group
Group type: EXPERIMENTAL
Intervention: 5mg prednisolone (morning or evening)
Number of subjects: 8
Study 28688245 — intervention group
Group type: COMPARATOR
Intervention: 5mg prednisolone in the morning
Number of subjects: 8
Study 26604737 — intervention group
Group type: EXPERIMENTAL
Intervention: SFC250 + TIO
Number of subjects: 53
Study 26604737 — intervention group
Group type: COMPARATOR
Intervention: TIO
Number of subjects: 53
Study 26604737 — intervention group
Group type: COMPARATOR
Intervention: SFC250
Number of subjects: 53
Study 23815878 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise supported by Peer Mentors
Number of subjects: 0
Study 23815878 — intervention group
Group type: EXPERIMENTAL
Intervention: Class-based exercise
Number of subjects: 0
Study 23815878 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 21088669 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium intake
Number of subjects: 0
Study 21088669 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH dietary pattern
Number of subjects: 0
Study 19204207 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 110
Study 19204207 — intervention group
Group type: COMPARATOR
Intervention: Temozolomide or Carmustine (BCNU)
Number of subjects: 110
Study 17539852 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids and long-acting beta(2)-agonists
Number of subjects: 20
Study 17539852 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study 16252738 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh needle penetration in anterior hard palate
Number of subjects: 24
Study 16252738 — intervention group
Group type: EXPERIMENTAL
Intervention: Used needle penetration in buccal mucosa (women)
Number of subjects: 24
Study 16252738 — intervention group
Group type: COMPARATOR
Intervention: Used needle penetration in buccal mucosa (men)
Number of subjects: 24
Study 12030995 — intervention group
Group type: EXPERIMENTAL
Intervention: Premedication with morphine, atropine and suxamethonium
Number of subjects: 20
Study 12030995 — intervention group
Group type: COMPARATOR
Intervention: Awake intubation
Number of subjects: 20
Study 12030995 — intervention group
Group type: EXPERIMENTAL
Intervention: Premedicated group
Number of subjects: 20
Study 12030995 — intervention group
Group type: COMPARATOR
Intervention: Unpremedicated group
Number of subjects: 20
Study 9593989 — intervention group
Group type: EXPERIMENTAL
Intervention: More frequent trials in one direction (2:1 ratio)
Number of subjects: 0
Study 9593989 — intervention group
Group type: COMPARATOR
Intervention: Less frequent trials in the opposite direction
Number of subjects: 0
Study 7636452 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 0
Study 7636452 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2677375 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 12
Study 2677375 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 12
Study 2677375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 100624 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (4 tablets: trimethoprim 320 mg, sulfamethoxazole 1,600 mg) twice daily for two days
Number of subjects: 89
Study 100624 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin (3.5 g) plus probenecid (1 g) in a single dose
Number of subjects: 89
Study 30869027 — intervention group
Group type: EXPERIMENTAL
Intervention: Dromedary camels
Number of subjects: 86
Study 30869027 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedouins
Number of subjects: 86
Study 30869027 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Bedouin Arabs
Number of subjects: 86
Study 30869027 — intervention group
Group type: COMPARATOR
Intervention: Jews
Number of subjects: 86
Study 30869027 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group ⩾40 years old in Bedouins
Number of subjects: 86
Study 30869027 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group ⩾40 years old in non-Bedouin Arabs
Number of subjects: 86
Study 28183155 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim analyses with early stopping for futility
Number of subjects: 0
Study 28183155 — intervention group
Group type: EXPERIMENTAL
Intervention: Completed studies without stopping for futility
Number of subjects: 0
Study 28183155 — intervention group
Group type: EXPERIMENTAL
Intervention: Single study with stopping rule
Number of subjects: 0
Study 28183155 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim analysis
Number of subjects: 0
Study 25937021 — intervention group
Group type: EXPERIMENTAL
Intervention: CPIHD with hypertonic saline (3% NaCl)
Number of subjects: 64
Study 25937021 — intervention group
Group type: COMPARATOR
Intervention: CPIHD with normal saline (0.9% NaCl)
Number of subjects: 64
Study 23676630 — intervention group
Group type: EXPERIMENTAL
Intervention: Model based on anthropometric measurements
Number of subjects: 91
Study 23676630 — intervention group
Group type: EXPERIMENTAL
Intervention: ViScan abdominal bioelectrical impedance analyzer
Number of subjects: 91
Study 21270788 — intervention group
Group type: EXPERIMENTAL
Intervention: NicVAX (3'AmNic‐rEPA) 400-µg dose, five injections
Number of subjects: 301
Study 21270788 — intervention group
Group type: EXPERIMENTAL
Intervention: NicVAX (3'AmNic‐rEPA) 200-µg dose, four or five injections
Number of subjects: 301
Study 21270788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 20084933 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion treatment
Number of subjects: 90
Study 20084933 — intervention group
Group type: COMPARATOR
Intervention: Control group (no moxibustion)
Number of subjects: 90
Study 16485612 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga for children
Number of subjects: 19
Study 16485612 — intervention group
Group type: COMPARATOR
Intervention: Conventional motor exercises
Number of subjects: 19
Study 16485612 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga for children (in children undergoing pharmacotherapy)
Number of subjects: 19
Study 15336451 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN plus ribavirin
Number of subjects: 311
Study 15336451 — intervention group
Group type: COMPARATOR
Intervention: Standard interferon alfa‐2b (IFN) plus ribavirin
Number of subjects: 311
Study 10847665 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical exercise
Number of subjects: 110
Study 10847665 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation
Number of subjects: 110
Study 10847665 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure and cholesterol change
Number of subjects: 110
Study 10847665 — intervention group
Group type: EXPERIMENTAL
Intervention: Total risk change
Number of subjects: 110
Study 7475056 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 28
Study 7475056 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 28
Study 2345836 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 22071
Study 2345836 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene
Number of subjects: 22071
Study 2345836 — intervention group
Group type: COMPARATOR
Intervention: Design strategies
Number of subjects: 22071
Study 6985881 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 28
Study 6985881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 29696643 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 12
Study 29696643 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel and ritonavir combination
Number of subjects: 12
Study 29696643 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir
Number of subjects: 12
Study 24828082 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal, school-based intervention for depression
Number of subjects: 5633
Study 24828082 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 5633
Study 24828082 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal, school-based intervention for depression (intent-to-treat sample)
Number of subjects: 5633
Study 22270733 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic position-adaptive stimulation (AdaptiveStim)
Number of subjects: 79
Study 22270733 — intervention group
Group type: COMPARATOR
Intervention: Manual programming adjustment
Number of subjects: 79
Study 22270733 — intervention group
Group type: EXPERIMENTAL
Intervention: Position-adaptive stimulation
Number of subjects: 79
Study 22270733 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 79
Study 21054860 — intervention group
Group type: EXPERIMENTAL
Intervention: LUCAS-2 mechanical compression device
Number of subjects: 4000
Study 21054860 — intervention group
Group type: COMPARATOR
Intervention: Manual chest compression (control)
Number of subjects: 4000
Study 17991232 — intervention group
Group type: EXPERIMENTAL
Intervention: Robinson bristle brush with pumice/water slurry (RBP)
Number of subjects: 45
Study 17991232 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalpel blade scraping (SBS)
Number of subjects: 45
Study 17991232 — intervention group
Group type: COMPARATOR
Intervention: Control group (cemental periodontal ligament preserved)
Number of subjects: 45
Study 15863111 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical mechanics techniques
Number of subjects: 0
Study 15863111 — intervention group
Group type: COMPARATOR
Intervention: Traditional posturographic measures
Number of subjects: 0
Study 15863111 — intervention group
Group type: EXPERIMENTAL
Intervention: Hurst rescaled range analysis
Number of subjects: 0
Study 15863111 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilogram diffusion analysis
Number of subjects: 0
Study 11920976 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 101
Study 11920976 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 101
Study 11920976 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT and antidepressant medication
Number of subjects: 101
Study 11920976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 10464889 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500 mg twice daily for 7 days)
Number of subjects: 327
Study 10464889 — intervention group
Group type: COMPARATOR
Intervention: Co-amoxiclav (625 mg three times daily for 7 days)
Number of subjects: 327
Study 10464889 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 327
Study 10464889 — intervention group
Group type: COMPARATOR
Intervention: Co-amoxiclav
Number of subjects: 327
Study 7605757 — intervention group
Group type: COMPARATOR
Intervention: 10 mL 0.125% bupivacaine plain solution (group B)
Number of subjects: 22
Study 7605757 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL 0.125% bupivacaine with 75 micrograms clonidine (group B + C)
Number of subjects: 22
Study 2194767 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (20 mg, up to 10 squares/day)
Number of subjects: 7
Study 2194767 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 7
Study 7395237 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg mesterolone per day for 8 weeks
Number of subjects: 17
Study 7395237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 31548106 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspire 8F (Sorin) oxygenator
Number of subjects: 25
Study 31548106 — intervention group
Group type: COMPARATOR
Intervention: Affinity Fusion (Medtronic) oxygenator
Number of subjects: 25
Study 31548106 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial and oxygenator exhaust correlations
Number of subjects: 25
Study 31164375 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time feedback
Number of subjects: 66
Study 31164375 — intervention group
Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 66
Study 31164375 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescue breaths
Number of subjects: 66
Study 28699832 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo stimulant medication
Number of subjects: 166
Study 28699832 — intervention group
Group type: COMPARATOR
Intervention: No medication (control)
Number of subjects: 166
Study 25025936 — intervention group
Group type: EXPERIMENTAL
Intervention: Core training (3 times/wk for 12 weeks)
Number of subjects: 20
Study 23649919 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal lidocaine (3 ml 4% lidocaine via LITA tube)
Number of subjects: 60
Study 23649919 — intervention group
Group type: COMPARATOR
Intervention: Intravenous remifentanil alone (control group)
Number of subjects: 60
Study 21178763 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% saline per 6% dextran 70 (hypertonic saline/dextran, HSD)
Number of subjects: 853
Study 21178763 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% saline (hypertonic saline, HS)
Number of subjects: 853
Study 21178763 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (normal saline, NS)
Number of subjects: 853
Study 21178763 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic fluids (HSD and HS)
Number of subjects: 853
Study 19246317 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl injected within 2 s into the forearm veins (Group A)
Number of subjects: 75
Study 19246317 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl injected in 2 s through the dorsal foot veins or the great saphenous vein (Group B)
Number of subjects: 75
Study 19246317 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl injected in 15 s through the same route as in Group A (Group C)
Number of subjects: 75
Study 17846070 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise programme
Number of subjects: 26
Study 17846070 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital exercise under physiotherapist supervision
Number of subjects: 26
Study 17846070 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 26
Study 16469151 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO drink (75 g glucose and 93 g Polyjoule, 2732 kJ, 653 kcal)
Number of subjects: 12
Study 16469151 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat drink (88% fat, cream blended with milk, 2732 kJ, 653 kcal)
Number of subjects: 12
Study 16469151 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study 16469151 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO drink
Number of subjects: 12
Study 16469151 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat drink
Number of subjects: 12
Study 15243149 — intervention group
Group type: EXPERIMENTAL
Intervention: CEMRA using ECST method
Number of subjects: 167
Study 15243149 — intervention group
Group type: EXPERIMENTAL
Intervention: CEMRA using NASCET method
Number of subjects: 167
Study 15243149 — intervention group
Group type: COMPARATOR
Intervention: DSA (reference standard)
Number of subjects: 167
Study 15243149 — intervention group
Group type: EXPERIMENTAL
Intervention: CEMRA and DSA
Number of subjects: 167
Study 10674507 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric lidocaine 2%
Number of subjects: 40
Study 10674507 — intervention group
Group type: COMPARATOR
Intervention: Isobaric lidocaine 2%
Number of subjects: 40
Study 8739453 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic leukocyte immunization
Number of subjects: 0
Study 8739453 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg)
Number of subjects: 0
Study 8739453 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 1856429 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 41
Study 1856429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 6178282 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine, 1 mg/kg per day, increased by 1 mg/kg every other day until suppression of ventricular premature complexes or maximum dose of 5 mg/kg per day.
Number of subjects: 22
Study 6178282 — intervention group
Group type: COMPARATOR
Intervention: Imipramine, 5 mg/kg per day.
Number of subjects: 22
Study 6178282 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (parent compound).
Number of subjects: 22
Study 6178282 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine.
Number of subjects: 22
Study 31295395 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.454% stannous fluoride dentifrice (Procter & Gamble)
Number of subjects: 36
Study 31295395 — intervention group
Group type: COMPARATOR
Intervention: Control dentifrice containing 0.243% sodium fluoride and 0.3% triclosan (Colgate‐Palmolive)
Number of subjects: 36
Study 27862646 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person and online LILAC intervention
Number of subjects: 39
Study 27862646 — intervention group
Group type: COMPARATOR
Intervention: In-person attention-matched control
Number of subjects: 39
Study 25997544 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg febuxostat
Number of subjects: 30
Study 25997544 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg febuxostat
Number of subjects: 30
Study 25997544 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (80 mg)
Number of subjects: 30
Study 25997544 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (40 mg)
Number of subjects: 30
Study 25616350 — intervention group
Group type: EXPERIMENTAL
Intervention: Air cholangiogram
Number of subjects: 49